CYTORI THERAPEUTICS, INC. FORM DEF14A

Company

PLUS THERAPEUTICS, INC.

Filed

April 30, 2010

Period of Report

August 5, 2010

Accession Number

0001095981-10-000007

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →